Am I eligible for this study? Stage I-III, non-metastatic breast cancer survivors who are 18 years of age or older and are 6 months to 5 years post-treatment with cancer-related cognitive impairment (CRCI) are eligible to participate in the NRG-CC011 study.Cancer-related cognitive impairment is when a person has trouble concentrating, learning new things, remembering, or […]
Read MoreAbout This Study NRG-CC011 is a clinical study trying to determine if computerized cognitive training can improve cancer-related cognitive impairment including the ability to concentrate, learn new things, remember, and make decisions that affect daily life in breast cancer survivors. We are doing this study to determine the usefulness of computerized cognitive […]
Read MoreClinical Studies FAQ
Read MoreThe NRG-C Study FAQ
Read MoreAm I eligible for this study? If you over the age of 18 with high-risk prostate cancer, you may be able to participate. Your healthcare team is the best source for information about your treatment options, including cancer clinical trials. Be sure to take this information to your doctor to discuss your questions and concerns […]
Read MoreAbout This Study ..NRG-GU013 is a clinical study for people with high-risk prostate cancer. Currently, patients with this type of cancer are treated with surgery, radiation, or hormone therapy drugs that are approved by the Food and Drug Administration (FDA). Sometimes a combination of these treatments is used. NRG-GU013 will be testing if radiation delivered […]
Read MoreClinical Studies FAQ
Read MoreThe NRG-GU013 Study FAQ
Read More